Literature DB >> 1392356

Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels.

R Chierici1, G Sawatzki, L Tamisari, S Volpato, V Vigi.   

Abstract

Breast milk provides an excellent supply of most nutrients for newborn infants. Infant formulae should be nutritionally comparable to breast milk especially with regard to critical nutrients like iron and other trace elements. Infant formulae supplemented with various amounts of bovine lactoferrin were given to two groups of infants. These infants were compared with infants receiving unsupplemented formula and breast-fed infants. The effects of these diets on levels of haemoglobin, haematocrit, serum iron, ferritin and zinc were examined for a study period of 150 days. At birth, concentrations of iron, haemoglobin, haematocrit and zinc were comparable in all four feeding groups. The fact that the serum zinc level was not altered by lactoferrin supplementation appears to rule out an in-vivo effect of lactoferrin on zinc nutrition of infants. Ferritin levels of breast-fed infants were significantly higher than in non-supplemented formula-fed infants at day 30 and day 90. This difference was seen only at day 30, when comparing breast-fed infants to lactoferrin-supplemented formula-fed infants. Comparing the infants receiving formulae, the formula supplemented with the higher amount of bovine lactoferrin induced significantly higher serum ferritin levels compared to the unsupplemented formula at day 90 and day 150. These observations favour the idea that lactoferrin may be involved in iron absorption. Since this effect was pronounced only after 90 days, it has to be discussed as to whether this effect is a convincing argument for supplementing infant formulae with bovine lactoferrin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392356     DOI: 10.1111/j.1651-2227.1992.tb12277.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children.

Authors:  Theresa J Ochoa; Elsa Chea-Woo; Miguel Campos; Iris Pecho; Ana Prada; Robert J McMahon; Thomas G Cleary
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

2.  Connective tissue: Vascular and hematological (blood) support.

Authors:  Nick Calvino
Journal:  J Chiropr Med       Date:  2003

3.  Lactoferrin versus iron hydroxide polymaltose complex for the treatment of iron deficiency anemia in children with cerebral palsy: a randomized controlled trial.

Authors:  Omneya M Omar; Hala Assem; Doaa Ahmed; Marwa S Abd Elmaksoud
Journal:  Eur J Pediatr       Date:  2021-05-28       Impact factor: 3.183

Review 4.  Clinical research review: usefulness of bovine lactoferrin in child health.

Authors:  Momoko Miyakawa; Hirotsugu Oda; Miyuki Tanaka
Journal:  Biometals       Date:  2022-08-09       Impact factor: 3.378

Review 5.  Lactoferrin: from the structure to the functional orchestration of iron homeostasis.

Authors:  Giusi Ianiro; Luigi Rosa; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci; Antimo Cutone
Journal:  Biometals       Date:  2022-10-10       Impact factor: 3.378

Review 6.  Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores.

Authors:  Franziska Roth-Walter
Journal:  Front Allergy       Date:  2022-05-10

Review 7.  Effect of lactoferrin on enteric pathogens.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Biochimie       Date:  2008-04-18       Impact factor: 4.079

8.  Hemoglobin cut-off values in healthy Turkish infants.

Authors:  Ahmet Arvas; Emel Gür; Durmuş Doğan
Journal:  World J Pediatr       Date:  2014-03-06       Impact factor: 2.764

9.  Reducing Iron Content in Infant Formula from 8 to 2 mg/L Does Not Increase the Risk of Iron Deficiency at 4 or 6 Months of Age: A Randomized Controlled Trial.

Authors:  Maria Björmsjö; Olle Hernell; Bo Lönnerdal; Staffan K Berglund
Journal:  Nutrients       Date:  2020-12-22       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.